Cargando…
1例3次挑战培美曲塞方案治疗晚期非小细胞肺癌有效的个案报道
Non-small cell lung cancer (NSCLC) accounts for about 85% of lung cancer, with a 5-year survival rate of less than 15%-19%, and more than 80% of the patients with lung cancer have progressed to advanced stage (Stage Ⅲb-Ⅳ) when they are clearly diagnosed. The comprehensive treatment mainly based on c...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580086/ https://www.ncbi.nlm.nih.gov/pubmed/31196375 http://dx.doi.org/10.3779/j.issn.1009-3419.2019.06.11 |